IGC Announces Results of its 2021 Annual Stockholders Meeting Oct 15, 2021 04:00PM
India Globalization Capital, Inc. (IGC) Reports Phase 1 Trial Results on Alzheimer’s Patients Sep 8, 2021 06:14AM
IGC Completes its Phase 1 Clinical Trial on Alzheimer’s Patients, Reports Safety and Tolerability Sep 7, 2021 07:30PM
IGC Reports Financial Results for the June 30, 2021, Quarter Aug 11, 2021 08:00PM
India Globalization Capital (IGC) Announces Issuance of Patent for the Treatment of Alzheimer's Disease Using THC Jul 22, 2021 07:34AM
View Older Stories

Jul 22, 2021 07:00AM IGC Announces Issuance of Patent for the Treatment of Alzheimer’s Disease Using THC
Mar 8, 2021 06:33PM IGC Receives Another Patent for a Cannabinoid-Based Cream for Treating Pain
Feb 22, 2021 08:05AM India Globalization Capital, Inc. (IGC) Announces Update On Phase 1 Clinical Trial on Alzheimer's Patients
Feb 22, 2021 08:00AM Update On IGC’s Phase 1 Clinical Trial on Alzheimer’s Patients
Feb 12, 2021 07:00PM IGC Reports Financial Results for December 31, 2020 Quarter
Jan 13, 2021 06:19PM IGC Announces Results of its 2020 Annual Stockholders Meeting
Nov 23, 2020 09:00AM IGC Commences Phase 1 of Cannabinoid Clinical Trial for Alzheimer’s Patients
Nov 22, 2020 08:48PM IGC Reports Financial Results for September 30, 2020 Quarter and Start of Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients
Aug 19, 2020 04:18PM IGC Reports Financial Results for the Quarter Ended June 30, 2020 While Preparing for Its FDA-Approved Cannabinoid Clinical Trials on Alzheimer’s Patients
Aug 19, 2020 04:18PM CORRECTING and REPLACING IGC Reports Financial Results for June 30, 2020 Quarter and Prepares for Phase 1 Cannabinoid Clinical Trial for Alzheimer’s Patients
Aug 11, 2020 05:06PM India Globalization Capital, Inc. (IGC) Announces FDA Approves Initiation of its Cannabinoid Trial on Alzheimer's Patients
Aug 11, 2020 05:03PM FDA Approves Initiation of IGC’s Cannabinoid Trial on Alzheimer’s Patients
Jul 21, 2020 07:05AM India Globalization Capital, Inc. (IGC) Files Patent Application with the U.S. Patent Office for a New Formulation to Treat Pain
Jul 21, 2020 07:00AM IGC Filed a Patent Application with the U.S. Patent Office for a New Formulation to Treat Pain
Jul 20, 2020 07:00AM IGC Receives a Notice of Allowance from the U.S. Patent Office
Jul 13, 2020 04:45PM IGC Reports Financial Results for the Fiscal Year Ended March 31, 2020
May 7, 2020 10:00PM India Globalization Capital, Inc. Announces Proposed Settlement of Three Derivative Lawsuits and Provides Notice to Shareholders
Mar 26, 2020 08:30PM IGC Receives New Patent from U.S. Patent Office to Treat Cachexia and Eating Disorders in Humans and Veterinary Animals
Feb 10, 2020 05:30PM IGC Reports Financial Results for the Quarter Ended December 31, 2019
Nov 6, 2019 07:00AM IGC Reports Financial Results for the Quarter Ended September 30, 2019
Oct 4, 2019 07:00AM IGC Opens Marketing and Research Hub in Colombia
Sep 19, 2019 07:03AM India Globalization Capital, Inc. (IGC) Reports IRB Approval of IGC-AD1 for Phase-2 Study
Sep 19, 2019 07:00AM IGC Announces IRB Approval of its IGC-AD1 for a Phase-2 study
Aug 9, 2019 07:00AM IGC Reports Financial Results for the Quarter Ended June 30, 2019
Jun 17, 2019 07:00AM IGC Reports Financial Results for the Fiscal Year Ended March 31, 2019
Jun 13, 2019 05:32PM IGC to Participate in Arizona’s Industrial Hemp Program
Apr 22, 2019 07:00AM IGC Announces Continued Educational Initiatives in Support of Hyalolex
Mar 27, 2019 06:17AM IGC (IGC) says its cannabinoid-based, non-FDA approved product to assist in improve lives of patients with Alzheimer's disease will be available for purchase in San Juan
Mar 26, 2019 09:00PM IGC Provides Corporate Updates
Feb 21, 2019 07:52PM IGC Announces Successful Appeal of Delisting Proceedings and Imminent Relisting on NYSE American
Oct 30, 2018 07:00AM IGC to Re-list Securities on Alternative Exchange
Oct 29, 2018 06:40PM NYSE American to Suspend Trading in India Globalization Capital and Commence Delisting Proceedings
Oct 10, 2018 07:21AM India Globalization Capital, Inc. (IGC) Files Provisional Patent to Protect IP for CBD-Infused Energy Drink
Oct 9, 2018 06:09PM IGC Files Provisional Patent to Protect IP for CBD-Infused Energy Drink
Oct 3, 2018 05:52AM India Globalization Capital, Inc. (IGC) Prices 5.65M Share At-the-Market Offering at Approx. $5.30/Sh
Oct 2, 2018 08:40PM IGC Completes At-The-Market Offerings
Sep 26, 2018 06:25AM India Globalization Capital (IGC) to Enter Hemp/CBD-Infused Energy Drink Space
Sep 25, 2018 08:39PM IGC to Enter the Hemp/CBD-Infused Energy Drink Space
Sep 13, 2018 07:00AM India Globalization Capital Raises $1 Million in Direct Equity Investment to Support Hyalolex Commercialization
Aug 14, 2018 07:00AM IGC to Enter California Market with Hyalolex
Aug 6, 2018 09:00PM IGC Announces Results of its 2018 Annual Stockholders Meeting
Aug 2, 2018 07:00PM IGC Announces Financial Results for Quarter Ended June 30, 2018
Jul 25, 2018 08:00AM IGC Announces “Drops of Clarity” Marketing Initiatives for Hyalolex™
Jul 10, 2018 07:00AM IGC Annual Meeting of Stockholders: August 6, 2018
Apr 10, 2018 07:00AM India Globalization Capital Files Patent for Hyalolex Formulation
Mar 26, 2018 09:44AM Puerto Rican Alzheimer’s Patients to Be First in U.S. to Obtain Cannabis-Based Relief
Mar 14, 2018 09:00AM IGC Partners to Advance Cannabinoid Based Parkinson's Disease Therapy Research -- CFN Media
Mar 12, 2018 08:00AM India Globalization Capital Appoints Carrolee Barlow, MD, PhD as Advisor to Help Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD
Mar 1, 2018 08:00AM India Globalization Capital Partners with Parkinson’s Institute and Clinical Center to Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorde
Feb 20, 2018 09:14AM IGC Announces Third Quarter Financial Results Advances Hyalolex to Commercialization Stage
View Older Stories